334 related articles for article (PubMed ID: 15955100)
1. Role of the chemokine receptor CCR4 and its ligand thymus- and activation-regulated chemokine/CCL17 for lymphocyte recruitment in cutaneous lupus erythematosus.
Wenzel J; Henze S; Wörenkämper E; Basner-Tschakarjan E; Sokolowska-Wojdylo M; Steitz J; Bieber T; Tüting T
J Invest Dermatol; 2005 Jun; 124(6):1241-8. PubMed ID: 15955100
[TBL] [Abstract][Full Text] [Related]
2. C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential.
Andrew DP; Ruffing N; Kim CH; Miao W; Heath H; Li Y; Murphy K; Campbell JJ; Butcher EC; Wu L
J Immunol; 2001 Jan; 166(1):103-11. PubMed ID: 11123282
[TBL] [Abstract][Full Text] [Related]
3. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin.
Vestergaard C; Bang K; Gesser B; Yoneyama H; Matsushima K; Larsen CG
J Invest Dermatol; 2000 Oct; 115(4):640-6. PubMed ID: 10998136
[TBL] [Abstract][Full Text] [Related]
4. Production of thymus and activation-regulated chemokine and macrophage-derived chemokine by CCR4+ adult T-cell leukemia cells.
Shimauchi T; Imai S; Hino R; Tokura Y
Clin Cancer Res; 2005 Mar; 11(6):2427-35. PubMed ID: 15788694
[TBL] [Abstract][Full Text] [Related]
5. Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine.
Richardson SK; Newton SB; Bach TL; Budgin JB; Benoit BM; Lin JH; Yoon JS; Wysocka M; Abrams CS; Rook AH
Am J Hematol; 2007 Sep; 82(9):792-7. PubMed ID: 17546636
[TBL] [Abstract][Full Text] [Related]
6. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.
Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Asahina A; Onai N; Matsushima K; Tamaki K
J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957
[TBL] [Abstract][Full Text] [Related]
7. The expression of human leukocyte antigen-DR and CD25 on circulating T cells in cutaneous lupus erythematosus and correlation with disease activity.
Wenzel J; Henze S; Brähler S; Bieber T; Tüting T
Exp Dermatol; 2005 Jun; 14(6):454-9. PubMed ID: 15885081
[TBL] [Abstract][Full Text] [Related]
8. Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein MxA.
Wenzel J; Uerlich M; Wörrenkämper E; Freutel S; Bieber T; Tüting T
Br J Dermatol; 2005 Nov; 153(5):1011-5. PubMed ID: 16225615
[TBL] [Abstract][Full Text] [Related]
9. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus.
Wenzel J; Wörenkämper E; Freutel S; Henze S; Haller O; Bieber T; Tüting T
J Pathol; 2005 Mar; 205(4):435-42. PubMed ID: 15685590
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of CCL17, CCL22 and CCR4 in drug-induced maculopapular exanthema.
Tapia B; Morel E; Martín-Díaz MA; Díaz R; Alves-Ferreira J; Rubio P; Padial A; Bellón T
Clin Exp Allergy; 2007 May; 37(5):704-13. PubMed ID: 17456218
[TBL] [Abstract][Full Text] [Related]
11. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin.
Reiss Y; Proudfoot AE; Power CA; Campbell JJ; Butcher EC
J Exp Med; 2001 Nov; 194(10):1541-7. PubMed ID: 11714760
[TBL] [Abstract][Full Text] [Related]
12. Thymus- and activation-regulated chemokine (TARC/CCL17) induces a Th2-dominated inflammatory reaction on intradermal injection in mice.
Vestergaard C; Deleuran M; Gesser B; Larsen CG
Exp Dermatol; 2004 Apr; 13(4):265-71. PubMed ID: 15086343
[TBL] [Abstract][Full Text] [Related]
13. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides.
Kakinuma T; Sugaya M; Nakamura K; Kaneko F; Wakugawa M; Matsushima K; Tamaki K
J Am Acad Dermatol; 2003 Jan; 48(1):23-30. PubMed ID: 12522366
[TBL] [Abstract][Full Text] [Related]
14. High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid.
Kakinuma T; Wakugawa M; Nakamura K; Hino H; Matsushima K; Tamaki K
Br J Dermatol; 2003 Feb; 148(2):203-10. PubMed ID: 12588369
[TBL] [Abstract][Full Text] [Related]
15. Increased CCR4 expression in cutaneous T cell lymphoma.
Ferenczi K; Fuhlbrigge RC; Pinkus J; Pinkus GS; Kupper TS
J Invest Dermatol; 2002 Dec; 119(6):1405-10. PubMed ID: 12485447
[TBL] [Abstract][Full Text] [Related]
16. A Th2 chemokine, TARC, produced by trophoblasts and endometrial gland cells, regulates the infiltration of CCR4+ T lymphocytes into human decidua at early pregnancy.
Tsuda H; Michimata T; Hayakawa S; Tanebe K; Sakai M; Fujimura M; Matsushima K; Saito S
Am J Reprod Immunol; 2002 Jul; 48(1):1-8. PubMed ID: 12322891
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of CCR4-expressing CD4+ T cells and high concentration of its ligands (TARC and MDC) in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia.
Katoh S; Fukushima K; Matsumoto N; Matsumoto K; Abe K; Onai N; Matsushima K; Matsukura S
Allergy; 2003 Jun; 58(6):518-23. PubMed ID: 12757454
[TBL] [Abstract][Full Text] [Related]
18. Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris.
Rottman JB; Smith TL; Ganley KG; Kikuchi T; Krueger JG
Lab Invest; 2001 Mar; 81(3):335-47. PubMed ID: 11310827
[TBL] [Abstract][Full Text] [Related]
19. A role for TARC/CCL17, a CC chemokine, in systemic lupus erythematosus.
Okamoto H; Koizumi K; Yamanaka H; Saito T; Kamatani N
J Rheumatol; 2003 Nov; 30(11):2369-73. PubMed ID: 14677179
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome.
Ishida T; Utsunomiya A; Iida S; Inagaki H; Takatsuka Y; Kusumoto S; Takeuchi G; Shimizu S; Ito M; Komatsu H; Wakita A; Eimoto T; Matsushima K; Ueda R
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3625-34. PubMed ID: 14506150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
